SIAS
NKTR icon

Shine Investment Advisory Services’s Nektar Therapeutics NKTR Stock Holding History

Shine Investment Advisory Services’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1K Hold
2
– – ﹤0.01% 704
2020
Q2 		$1K Hold
2
– – ﹤0.01% 713
2020
Q1 		$1K Hold
2
– – ﹤0.01% 696
2019
Q4 		$1K Buy
+2
New +$580 ﹤0.01% 715

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Shine Investment Advisory Services's NKTR Position: Q3 2020 in Review

Shine Investment Advisory Services held its Nektar Therapeutics (NKTR) position steady in Q3 2020 at 2 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #704.

Shine Investment Advisory Services first reported a position in NKTR in Q4 2019 and has held it in 4 quarters since. 249 funds tracked by Wall St. Rank hold NKTR as of Q3 2020.

  • Shine Investment Advisory Services held 2 shares of Nektar Therapeutics worth $1K as of Q3 2020.
  • Shine Investment Advisory Services left its Nektar Therapeutics share count unchanged in Q3 2020.
  • Nektar Therapeutics made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #704 holding.
  • Shine Investment Advisory Services first reported a position in Nektar Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • 249 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.